19-50855432-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000601349.5(KLK3):​n.518C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.38 in 169,296 control chromosomes in the GnomAD database, including 12,717 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 11440 hom., cov: 31)
Exomes 𝑓: 0.36 ( 1277 hom. )

Consequence

KLK3
ENST00000601349.5 non_coding_transcript_exon

Scores

2
Splicing: ADA: 0.00005103
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.599

Publications

8 publications found
Variant links:
Genes affected
KLK3 (HGNC:6364): (kallikrein related peptidase 3) Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. It encodes a single-chain glycoprotein, a protease which is synthesized in the epithelial cells of the prostate gland, and is present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. The serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLK3NM_001648.2 linkc.46+431C>T intron_variant Intron 1 of 4 ENST00000326003.7 NP_001639.1 P07288-1Q546G3
KLK3NM_001030047.1 linkc.46+431C>T intron_variant Intron 1 of 4 NP_001025218.1 P07288-2
KLK3NM_001030048.1 linkc.46+431C>T intron_variant Intron 1 of 4 NP_001025219.1 P07288-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLK3ENST00000326003.7 linkc.46+431C>T intron_variant Intron 1 of 4 1 NM_001648.2 ENSP00000314151.1 P07288-1

Frequencies

GnomAD3 genomes
AF:
0.383
AC:
58062
AN:
151748
Hom.:
11427
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.362
Gnomad AMI
AF:
0.438
Gnomad AMR
AF:
0.441
Gnomad ASJ
AF:
0.333
Gnomad EAS
AF:
0.509
Gnomad SAS
AF:
0.220
Gnomad FIN
AF:
0.431
Gnomad MID
AF:
0.303
Gnomad NFE
AF:
0.379
Gnomad OTH
AF:
0.372
GnomAD4 exome
AF:
0.359
AC:
6260
AN:
17428
Hom.:
1277
Cov.:
0
AF XY:
0.354
AC XY:
3276
AN XY:
9256
show subpopulations
African (AFR)
AF:
0.364
AC:
150
AN:
412
American (AMR)
AF:
0.446
AC:
859
AN:
1924
Ashkenazi Jewish (ASJ)
AF:
0.318
AC:
147
AN:
462
East Asian (EAS)
AF:
0.514
AC:
362
AN:
704
South Asian (SAS)
AF:
0.197
AC:
305
AN:
1548
European-Finnish (FIN)
AF:
0.428
AC:
243
AN:
568
Middle Eastern (MID)
AF:
0.173
AC:
9
AN:
52
European-Non Finnish (NFE)
AF:
0.357
AC:
3867
AN:
10824
Other (OTH)
AF:
0.340
AC:
318
AN:
934
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
187
375
562
750
937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.383
AC:
58111
AN:
151868
Hom.:
11440
Cov.:
31
AF XY:
0.383
AC XY:
28403
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.362
AC:
14996
AN:
41390
American (AMR)
AF:
0.441
AC:
6734
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
1155
AN:
3470
East Asian (EAS)
AF:
0.508
AC:
2609
AN:
5132
South Asian (SAS)
AF:
0.220
AC:
1060
AN:
4828
European-Finnish (FIN)
AF:
0.431
AC:
4545
AN:
10552
Middle Eastern (MID)
AF:
0.288
AC:
84
AN:
292
European-Non Finnish (NFE)
AF:
0.379
AC:
25737
AN:
67932
Other (OTH)
AF:
0.378
AC:
796
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1807
3614
5422
7229
9036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.373
Hom.:
40242
Bravo
AF:
0.387

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
5.1
DANN
Benign
0.25
PhyloP100
-0.60
PromoterAI
-0.0053
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000051
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2292185; hg19: chr19-51358688; API